Adobe

STAT+ | Terminated NIH grants are being reinstated almost entirely in blue states

NIH grant restoration process plays out over landscape splintered by DEI restrictions, court order that applies in the blue states that sued

By Anil Oza

STAT+ | How the tax-cut bill that’s headed to Trump’s desk would upend health care

Trump is set to sign a bill that will make transformational changes to Medicaid and the ACA.

By Daniel Payne, Chelsea Cirruzzo, and John Wilkerson

STAT+ | How Dr. Oz helped seal the deal on Trump’s tax-cut bill

Mehmet Oz, head of the Centers for Medicare and Medicaid Services, worked to reassure lawmakers wary of deep health care cuts in Trump's tax bill.

By Chelsea Cirruzzo, John Wilkerson, and Daniel Payne

Molly Ferguson/STAT

STAT+ | The year is half over. Here’s where the biotech industry stands

In this week's "Adam's Biotech Scorecard," Adam also looks at a new trend: the Wall Street-to-pharma career arc.

By Adam Feuerstein

Opinion: The U.S. government is failing on vaccine policy. The Vaccine Integrity Project is here to help

The Vaccine Integrity Project to promote integrity and scientific rigor isn't intended to replace government bodies, writes CIDRAP's Michael Osterholm.

By Michael T. Osterholm

STAT+ | A GPT-powered medical device certified in Europe raises questions about generative AI in health care

Generative AI chatbot for doctors called "Prof. Valmed" earns EU approval. In the U.S., regulators haven't issued any guidelines on the technology's use in medicine.

By Brittany Trang

JALEES ANDRABI/AFPTV/AFP via Getty Images

Opinion: Protecting pilgrims from infectious disease without diminishing their faith

An infectious disease doctor in California is seeing patients who got sick during the Ganges pilgrimage in India.

By Jake Scott

Opinion: Tariffs can’t defeat the fentanyl problem in the US

While trade is the right venue to address fentanyl supply, tariffs are the wrong instrument.

By Kathleen J. Frydl